information crypto, snippets

The scale of China's AI core industry is nearly 600 billion yuan. Generative artificial intelligence enterprises set off a price war. According to the Report on the Development of Generative Artificial Intelligence Applications in 2024, as of June, the number of users of China's generative artificial intelligence products has reached 230 million. At present, the number of enterprises has exceeded 4,500, and the scale of core industries is close to 600 billion yuan. According to industry insiders, compared with the input cost of several billion yuan, the large model enterprises are not commercialized at present, and the realization is slow. A large number of generative artificial intelligence enterprises in the market, in order to compete for users, set off a round of computing power price war in the industry, and the price of large model computing power once dropped by as much as 90%. (CCTV Finance)Daiwa Capital Markets: The price of lithium may fall further in the first half of 2025. Daiwa Capital Markets said in a research report to customers that the global lithium supply is expected to increase by 12-28% in 2025-2026, which is due to the increase in production in major regions such as Argentina, Australia and Africa. However, the team warned that lithium prices may still be under pressure due to oversupply. At present, the price of LCE (lithium carbonate equivalent) in China is about 78,000 yuan/ton, but Yamato predicts that the price of LCE will be reduced to 75,000 yuan/ton by 2025 due to the increase in the output of low-cost mines. Yamato said: "The current price of lithium is not enough to prevent low-cost mines from increasing production." The demand for lithium, especially for electric vehicles (EV) and energy storage systems (ESS), is expected to slow down. Yamato believes that the slowdown in demand growth, coupled with the increase in supply, indicates that lithium prices may be difficult to maintain their recent highs.Meixin Technology: It plans to participate in the establishment of an industrial investment fund with 10 million yuan. Meixin Technology announced that the company, as a limited partner, plans to sign the "Xiamen Xibo Alpha Venture Capital Partnership Agreement" with Nantian Electric Power, Hai Venture Capital, Huli Investment, Zhilai Technology, Xibo Zhongfu, Hemei Information, Guangxi Wan 'an, Li Juan and Liao Qiuru to participate in the investment in Xiamen Xibo Alpha Venture Capital Partnership. The fund mainly invests in new-generation information technology, new materials, high-end equipment and other industrial fields, and the scale of raising funds has been expanded from 54 million yuan to 200 million yuan, of which the company plans to subscribe for 10 million yuan with its own funds.

Wang Zhonglin, Governor of Hubei Province had a discussion with He Xiaopeng, Chairman of Xpeng Motors. On the morning of December 9, Wang Zhonglin, Deputy Secretary of Hubei Provincial Party Committee and Governor, had a discussion with He Xiaopeng, Chairman and CEO of Xpeng Motors. Wang Zhonglin expressed the hope that Xpeng Motors will continue to deepen its cooperation with Hubei, further increase its investment layout in Hubei, expand cooperation space in new energy and intelligent networked vehicles, low-altitude economy, humanoid robots and other fields, promote more new technologies and new products to land in Hubei, and help Hubei forge ahead in promoting scientific and technological innovation and industrial innovation, and accelerate the cultivation and expansion of new quality productivity. He Xiaopeng said that Xpeng Motors will continue to regard Hubei as the key area of business layout, further increase its investment in Hubei, actively promote the transformation and upgrading of Hubei's automobile industry and the development and growth of emerging industries, and make new and greater contributions to accelerating the establishment of Hubei as an important strategic fulcrum for the rise of central China.Tongyizhong: It plans to acquire 75.8% of the shares of Chaomeisi New Materials with 243 million yuan. Tongyizhong announced that the company plans to acquire 75.80% of the shares of Chaomeisi New Materials Co., Ltd. with its own funds of 243 million yuan. After the completion of this transaction, Chaomeisi will become a holding subsidiary of the company.Haineng Industry: The controlling shareholder intends to reduce the company's shares by no more than 3%. Haineng Industry announced that Mr. Zhou Hongliang, the controlling shareholder, actual controller and chairman of the company, plans to reduce the company's shares by no more than 7,835,800 shares through centralized bidding and block trading from January 1, 2025 to March 31, 2025, accounting for 3% of the share capital after excluding the company's repurchase special account. Among them, it is planned to reduce the holding of no more than 2,611,900 shares through centralized bidding, accounting for 1% of the share capital after excluding the company's repurchase special account; It is planned to reduce its holdings by no more than 5,223,900 shares through block trading, accounting for 2% of the share capital after excluding the company's repurchase special account. Mr. Zhou Hongliang currently holds 136 million shares of the company, accounting for 52.10% of the share capital after excluding the company's repurchase special account. Due to the shareholders' own capital demand, this reduction will not lead to the change of the company's control rights, nor will it affect the company's governance structure and going concern.

Qatar Foreign Ministry spokesman: We are witnessing a historic moment in the region, which is the light of hope for the Syrian people to realize their ambitions.AstraZeneca's potential blockbuster ADC was recognized by the FDA. AstraZeneca and Thirteen announced that the FDA granted its Trop2 targeted antibody-coupled drug (ADC) Datopotamab Deruxtecan (Dato-DXD) breakthrough therapy recognition (BTD) to treat adult patients with locally advanced or metastatic epidermal growth factor receptor mutation (EGFRm) who are undergoing treatment.On December 17th, the M&A Committee of Shanghai Stock Exchange deliberated the issue of purchasing assets by issuing shares of Guolian Securities, and the M&A Committee of Shanghai Stock Exchange is scheduled to hold the 6th review meeting of the M&A Committee in 2024 on December 17th, 2024 to consider the issue of Guolian Securities Co., Ltd. (issuing shares to purchase assets).